海外の骨肉腫専門医 — ページ3

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Head of the Department is Dr. Netanel Meusher, a specialist in treatment of bone cancer

オフルオール教授は約30年の医療経験を有しています。彼はトルコのアンカラにあるガジ大学の医学部で教育を受けました。2000年に、オンダー・オフルオール教授はロシアのイリザロフ科学センターでイリザロフ手術のトレーニングを受けました。2002年には、アメリカ合衆国のペンシルバニア大学医学部およびフィラデルフィアの子ども病院で、子どもおよび成人の骨や軟部組織の腫瘍について学びました。オフルオール教授はまた、アメリカ合衆国のカリフォルニア大学で整形外科腫瘍学を学びました。

専門分野：

• 整形外科手術
• 整形外科腫瘍手術
• 手のマイクロサージェリー
• 骨と軟部組織の腫瘍
• 外傷手術

現在、オンダー・オフルオール医師はメディカルパーク・ギョズテペ病院で働いています。

オンダー・オフルオールは50以上の文書の著者および共著者であり、200以上の引用があります。

会員資格：

• 結合組織腫瘍学会;
• ヨーロッパ整形外科および外傷学会連盟;
• トルコ整形腫瘍学会;
• トルコ整形外科および外傷学会;
• イリザロフ法研究・応用協会。

ズヴィ・C・ジェイコブ博士は、小児麻酔学の分野で評判の高い人物です。彼の熟練は、一般麻酔、小児麻酔、小児患者における区域麻酔技術に及びます。彼は一連の成功したレジデンシーとフェローシップを完了し、医療分野での彼のコミットメントと専門性を示すボード認定を保持しています。ジェイコブ博士はまた、彼の多くの発表された研究と記事によって証明されているように、医学研究に大きく貢献しています。

学歴

• B.Med.Sc, テクニオン・ブルース・ラッパポート医学部, ハイファ, イスラエル, 1994
• M.D., テクニオン・ブルース・ラッパポート医学部, ハイファ, イスラエル, 1996
• インターンシップ, ランバム・メディカル・センター, ハイファ, イスラエル, 1996-97
• 整形外科レジデンシー, ランバム・メディカル・センター, ハイファ, イスラエル, 1997-2000
• 外科インターンシップ, バークシャー・メディカル・センター, ピッツフィールド, MA, 2000-01
• 麻酔学レジデンシー, ストーニー・ブルック病院, ストーニー・ブルック, NY, 2001-04
• 小児麻酔フェローシップ, コロンビア・プレスビテリアン・メディカル・センター, NY, 2004-05

所属

• アメリカ麻酔学会
• 小児麻酔学会
• ニューヨーク麻酔学会

資格

• アメリカ麻酔学会理事会による小児麻酔学の認定, 2013
• 麻酔学の理事会認定, 2005

Tamar Jablonski-Perec is an oncologist at the Hadassah Medical Center who received her Doctor of Medical Sciences at the Hebrew University in Jerusalem and completed an internship at the renowned Sloan-Kettering Cancer Center in New York. Her key takeaways include:

• Head of Institute of Oncology in 1994
• Head of Breast Cancer Treatment Center in 1998
• Professor of the Department of Oncology at the Hebrew University in 2006
• Member of several international cancer communities
• Awarded a scholarship from the Hadassah Medical School

Deputy Head of the Department of Oncology

Elke Jaeger教授は、1,100件以上の手術を行ったトップクラスの肉腫専門医であり、41年の経験にわたりドイツ最優秀腫瘍専門医の一人として評価されています。

• 腫瘍学における41年の経験の診療経験
• ノルトヴェスト・クリニック腫瘍・血液内科長
• 腫瘍内科学および血液学教授
• EORTC専門家委員会委員

Dr. Turkan Ozturk Topcu is a clinical oncologist at Biruni University Hospital in Istanbul. She maintains professional ties with the MD Anderson Cancer Center in the USA. She specializes in the treatment of breast, lung, and gastrointestinal cancers. Dr. Topcu is a member of both ESMO and ASCO.

• Completed a fellowship at the Sunnybrook Odette Cancer Center Breast Clinic in Canada.
• Treats a wide range of conditions including liver, pancreatic, and gynecological cancers.
• Held clinical roles at major institutions like Moffitt Cancer Center in the USA.
• Works at Biruni University Hospital, a TEMOS-accredited facility in Turkey.

Marmara University Faculty of Medicine, Department of Radiation Oncology Specialization training: 2012 -2016

Marmara University Faculty of Medicine (English) Undergraduate: 2004-2011

Sixteen Numbered Shirvan School (Azerbaijan) High School: 1998 -2004